The human body is estimated to be composed of several trillions of cells with over 200 different cell types identified yet. Cancer is a disorder that results from the dysregulation of growth of any of them, meaning that cells replicate in an uncontrolled manner. Although there are protective mechanisms to prevent this from happening, an undetected mutation in a single cell might be enough to initiate cancer development - fortunately this is very rare, more often it is a multistep process referred to as “cancerogenesis”. The cell from which the cancer originates can be in theory any within your body, but this depends on an individual's genetics, the environment, lifestyle and cell types, as many of them are more resistant to damage than others and rarely divide. Therefore it is not just one disease, but a large group of disorders with various origins.
The word “cancer” originated in ancient Greek, Hippocrates is said to have used the words “carcinos” and “carcinoma” due to the similarity in appearance of crabs and cancer lesions. Another word often used in the context of cancer is for example “oncology”, the study of cancer, which is derived from the old Greek word “oncos” translating to “swelling”.
“Cancer” is often used interchangeably with the word “malignancy”, referring to cell overgrowths (tumors) that invade tissue and spread through the body. In contrast to malignancies benign tumors are also overgrowths of cells, but they don’t invade adjacent tissue or spread and tend to cause only little troubles. Despite this, benign doesn't equal harmless, as even benign tumors can cause problems due to their local effects like e.g. compressing nearby structures.
It’s a subset of more than 100 genes that are tightly associated with cancer. They contribute to the dysregulation of a healthy cell. Since these genes are associated with the abnormal growth of tissue, they are usually found in all cells of one tumor, supporting the thesis that they were present in the founding cell, which initiated the development in the beginning.
They have been distributed into groups according to their function:
There are many possible types of mutations affecting the genome (e.g. point mutations, gene rearrangements, deletions, gene amplification, translocations, …) of which some might even be inherited. If they are not detected by protective mechanisms and either corrected or the affected cell is not killed, they fall into one of two categories:
Passenger mutations may be initially harmless, but might contribute to selective advantages of the cell later.
Cancerogenesis or the development of cancer is fortunately in most cases a multistep process and more than a single mutation in a cell is needed to trigger uncontrolled cell growth. The process of tumor progression is simplified below.
Figure 1: The development of cancer
Throughout the development of cancer many subtypes of cells emerge and some might replicate or invade tissue easier than others giving them a selective advantage due to Darwinian selection. Treatment might further accelerate this process and complicate the therapy later, as only resistant cells survive. Therefore cancer tends to become more aggressive over time.
Some types of cancers are already well researched and definit causes have been identified, whereas the pathogenesis of others remains unknown or is assumed to be the result of a complex interaction between several factors.
Generally cancer is divided into blood (hematogenous) and solid tumors.
In principle there are three ways how a tumor can spread from one location to the other.
A tumor that has spread to another location is by definition malignant, those tumor “offsprings” are called metastases. Not every tumor spreads in the same way, sarcomas tend to spread via blood and carcinomas via the lymphatic system. Certain types of cancers even have a “favorite” or more common location of metastases.
Cancer treatment is difficult and mostly performed by multidisciplinary teams. Over the last decade the treatment options and outcomes have improved greatly, therefore many types of cancers are nowadays treatable, but some remain virtually always lethal.
Combinations of several methods often achieve the best results, but the guidelines and evidence vary from type to type.
Early diagnosis of cancer usually improves the outcome by a lot, which is why many countries established screening programs. Breast, prostate, skin and colorectal cancers belong among those that are often integrated in these programs, check your national guidelines or ask your doctor if you are eligible for any of those screening programs.
Besides an early diagnosis, there are ways to reduce the risk of cancer from developing in the first place. Harvard medical school has published an article (2019) regarding 10 ways to reduce your risk of developing cancer.
As described before, chronic inflammatory states are associated with the development of cancer. Should you suffer from any condition like that, appropriate treatment is vital to improve your health and minimize the risk of developing cancer.
Get the guidelines for a healthier and longer life. With Macromo tests, you'll learn your health risks and how to prevent them.
Continue to Shop